合聘師資-中央大學生命科學系資訊網

‧ 個人資訊：https://cs.nhri.org.tw/investigators/%E8%A4%9A%E5%BF%97%E6%96%8C/

‧ 學歷：

The University of Chicago (Chicago, IL, U.S.A.) Committee on Cancer Biology 博士（2000-2005）

National Tsing Hua University (Hsinchu, Taiwan) Physics department 學士（1993-1997）

‧ 經歷：

July, 2015-present Associate Investigator, Institute of Cellular and System Medicine, National Health Research Institutes (Miaoli, Taiwan)

March, 2020-present Deputy Director of Student’s Affair Office, National Health Research Institutes (Miaoli, Taiwan)

September, 2009-June, 2015  Assistant Investigator, Institute of Cellular and System Medicine, National Health Research Institutes (Miaoli, Taiwan)

May, 2013-present  Academic Editor, PLOS One

January, 2010-present  Supervisor PI, Core Instrument Center Micro-Western Array core Lab, NHRI

August, 2016-present  Adjunct Associate Investigator, National Defense Medical Center

February, 2013-present  Adjunct Assistant Professor, Graduate Institute of Basic Medical Science, China Medical University (Taichung, Taiwan)

July, 2011-present  Adjunct Assistant Professor, Biotechnology Center, National Chung Hsing University (Taichung, Taiwan)

July, 2005-September, 2009  Postdoctoral Scholar, Ben May Department for Cancer Research & Institute for Genomics & System Biology, The University of Chicago (Chicago, IL, U.S.A.)

1.      Betel Nut Arecoline Induces Different Phases of Growth Arrest between Normal and Cancerous Prostate Cells through the Reactive Oxygen Species Pathway. Shih LJ, Wang JY, Jheng JY, Siao AC, Lin YY, Tsuei YW, Kuo YC, Chuu CP, Kao YH. Int J Mol Sci. 2020 Dec 3;21(23):9219.

2.      Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. Tseng LL, Cheng HH, Yeh TS, Huang SC, Syu YY, Chuu CP, Yuh CH, Kung HJ, Wang WC. Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24859-24866.

3.      Comparison of Clinical Manifestations, Treatments, and Outcomes between Vespidae Sting and Formicidae Sting Patients in the Emergency Department in Taiwan. Lin YY, Chiu CC, Chang HA, Kao YH, Hsiao PJ*, Chuu CP*. Int J Environ Res Public Health. 2020 Aug 25;17(17):6162. * co-corresponding author

4.      Endothelin-1 stimulates preadipocyte growth via the PKC, STAT3, AMPK, c-JUN, ERK, sphingosine kinase, and sphingomyelinase pathways. Siao AC, Lin YY, Shih LJ, Tsuei YW, Chuu CP, Kuo YC, Kao YH. Am J Physiol Cell Physiol. 2020 Nov 1;319(5):C839-C857.

5.      Usability of Wearable Devices With a Novel Cardiac Force Index for Estimating the Dynamic Cardiac Function: Observational Study. Hsiao PJ, Chiu CC, Lin KH, Hu FK, Tsai PJ, Wu CT, Pang YK, Lin Y, Kuo MH, Chen KH, Wu YS, Wu HY, Chang YT, Chang YT, Cheng CS, Chuu CP, Lin FH, Chang CW, Li YK, Chan JS, Chu CM. JMIR Mhealth Uhealth. 2020 Jul 21;8(7):e15331.

6.      ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis. Tseng JC, Huang SH, Lin CY, Wang BJ, Huang SF, Shen YY, Chuu CP*. Cell Death Dis. 2020 May 15;11(5):376. * corresponding author

7.      New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer. Lin CY, Chuu CP*. Transl Androl Urol. 2020 Apr;9(2):837-839. * corresponding author

8.      Aspalathin-rich green Aspalathus linearis extract suppresses migration and invasion of human castration-resistant prostate cancer cells via inhibition of YAP signaling. Huang SH, Kao YH, Muller CJF, Joubert E, Chuu CP*. Phytomedicine. 2020 Apr;69:153210. * corresponding author

9.      Comparison of fractional excretion of electrolytes in patients at different stages of chronic kidney disease: A cross-sectional study. Hsiao PJ*, Liao CY, Kao YH, Chan JS, Lin YF, Chuu CP*, Chen JS*. Medicine (Baltimore). 2020 Jan;99(2):e18709. * corresponding author

10.   Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc. Lin CY, Wang BJ, Chen BC, Tseng JC, Jiang SS, Tsai KK, Shen YY, Yuh CH, Sie ZL, Wang WC, Kung HJ, Chuu CP*. Cancers (Basel). 2019 Nov 13;11(11). * corresponding author

11.   Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213. Kuo YY, Huo C, Lin CY, Lin HP, Liu JS, Wang WC, Chang CR*, Chuu CP*. Cell Commun Signal. 2019 Aug 20;17(1):100. *co-corresponding author

12.   Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling. Huang SH, Tseng JC, Lin CY, Kuo YY, Wang BJ, Kao YH, Muller CJF, Joubert E, Chuu CP*. Phytomedicine. 2019 Nov;64:153068. * corresponding author

13.   Investigation of the relationship between non-ketotic hyperglycemia and hemichorea-hemiballism: A case report. Hsiao PJ, Kuo CC, Kuo TY, Kao YH, Chan JS, Lin YY, Chen MH*, Chen JS*, Chuu CP*. Medicine (Baltimore). 2019 Jul;98(28):e16255. *co-corresponding author

14.   CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. Lai CJ, Lin CY, Liao WY, Hour TC*, Wang HD*, Chuu CP*. Cells. 2019 Mar 30;8(4). pii: E295. doi: 10.3390/cells8040295. *co-corresponding author

15.   Ptosis and macroglossia in a woman with systemic light-chain amyloidosis. Hsiao PJ, Chang YC, Tsao YH, Wu KL, Kao YH, Chan JS, Wang CH, Lin YY, Chuu CP*, Lin YS*. Clin Chim Acta. 2019 Mar 21;494:112-115. doi: 10.1016/j.cca.2019.03.1624. * co-corresponding author

16.   TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility. Hsing EW, Shiah SG, Peng HY, Chen YW, Chuu CP, Hsiao JR, Lyu PC, Chang JY*. PLoS One. 2019 Mar 20;14(3):e0213463. doi: 10.1371/journal.pone.0213463. eCollection 2019.

17.   Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer. Yeh CC, Shih LJ, Chang JL, Tsuei YW, Wu CC, Hsiao CW, Chuu CP, Kao YH. Sci Rep. 2019 Mar 12;9(1):4228. doi: 10.1038/s41598-019-40862-6.

18.   KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis. Wu MC, Cheng HH, Yeh TS, Li YC, Chen TJ, Sit WY, Chuu CP, Kung HJ, Chien S, Wang WC. Cell Death Dis. 2019 Jan 25;10(2):68. doi: 10.1038/s41419-019-1305-y.

19.   Polymorphisms of suppressor of cytokine signaling-3 associated with susceptibility to tuberculosis among Han Taiwanese. Lin CJ, Lee SW, Liu CW, Chuu CP, Kao YH, Wu LS. Cytokine. 2019 Feb;114:11-17. doi: 10.1016/j.cyto.2018.11.026. Epub 2018 Dec 20.

20.  ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Hwang SP, Chen LT, Tsai KK. Oncogene. 2018 Sep 28. doi: 10.1038/s41388-018-0497-4. 

21.  Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5. Lin CY§, Jan YJ§, Kuo LK§, Wang BJ, Huo C, Jiang SS, Chen SC, Kuo YY, Chang CR, Chuu CP*. Cancer Sci. 2018 Aug 24. doi: 10.1111/cas.13776. § co-first author * corresponding author

22.        KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC. Wang HJ, Pochampalli M, Wang LY, Zou JX, Li PS, Hsu SC, Wang BJ, Huang SH, Yang P, Yang JC, Chu CY, Hsieh CL, Sung SY, Li CF, Tepper CG, Ann DK, Gao AC, Evans CP, Izumiya Y, Chuu CP, Wang WC, Chen HW, Kung HJ. Oncogene. 2018 Aug 2. doi: 10.1038/s41388-018-0414-x. 

23.        Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma. Li SM, Chen CH, Chen YW, Yen YC, Fang WT, Tsai FY, Chang JL, Shen YY, Huang SF, Chuu CP, Chang IS, Hsiung CA, Jiang SS*. Sci Rep. 2017 Sep 19;7(1):11893.

24.  Activation of liver X receptor suppresses angiogenesis via induction of ApoD. Lai CJ, Cheng HC, Lin CY, Huang SH, Chen TH, Chung CJ, Chang CH, Wang HD*, Chuu CP*. FASEB J. 2017 Dec;31(12):5568-5576. *co-corresponding author

25.    Suppressors of cytokine signaling in tuberculosis. Lee SW, Liu CW, Hu JY, Chiang LM, Chuu CP, Wu LS, Kao YH*. PLoS One. 2017 Apr 21;12(4):e0176377.

26.   YAP promotes myogenic differentiation via the MEK5-ERK5 pathway. Chen TH, Chen CY, Wen HC, Chang CC, Wang HD, Chuu CP*, Chang CH*. FASEB J. 2017 Jul;31(7):2963-2972. *co-corresponding author

27.   CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Tseng JC, Lin CY, Su LC, Fu HH, Yang SD*, Chuu CP*. Oncotarget. 2016 Jun 21;7(25):38010-38024. *co-corresponding author

28.  Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection via Breast Milk: A Two-Year Prospective Follow-Up Study. Jim WT, Chiu NC, Ho CS, Shu CH, Chang JH, Hung HY, Kao HA, Chang HY, Peng CC, Yui BH, Chuu CP. Medicine (Baltimore). 2015 Oct;94(43)

29. Akt3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, & TSC1/TSC2. Lin HP, Lin CY, Huo C, Jan YJ, Tseng JC, Jiang SS, Kuo YY, Chen SC, Wang CT, Chan TM, Liou JY, Wang J, Chang WW, Chang CH, Kung HJ, Chuu CP*. Oncotarget. 2015 Sep 29;6(29):27097-112. *corresponding author

30. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells. Huo C, Kao YH, Chuu CP*. Cancer Lett. 2015 Dec 1;369(1):103-11. *corresponding author

31.   CR3 and Dectin-1 Collaborate in Macrophage Cytokine Response through Association on Lipid Rafts and Activation of Syk-JNK-AP-1 Pathway. Huang JH, Lin CY, Wu SY,Chen WY,ChuCL, Brown GD, Chuu CP, Wu-Hsieh BA. PLoS Pathog. 2015 Jul 1;11(7):e1004985.

32.   SWAP-70 contributes to spontaneous transformation of mouse embryo fibroblasts. Chang YT, Shu CL, Lai JY, Ching-Yu L, Chuu CP, Morishita K, Ichikawa T, Jessberger R, Fukui Y. Exp Cell Res. 2016 Jul 15;345(2):150-7.

33. Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. Kuo YY, Jim WT, Su LC, Chung CJ, Lin CY, Huo C, Tseng JC, Huang SH, Lai CJ, Chen BC, Wang BJ, Chan TM, Lin HP, Chang WS, Chang CR, Chuu CP*. Int J Mol Sci. 2015 May 12;16(5):10748-10766. *corresponding author

34. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cheng HW, Liang YH, Kuo YL, Chuu CP, Lin CY, Lee MH, Wu AT, Yeh CT, Chen EI, Whang-Peng J, Su CL, Huang CY*. Cell Death Dis. 2015 May 7;6:e1753.

35. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells. Wen HC§, Chuu CP§, Chen CY, Shiah SG, Kung HJ, King KL, Su LC, Chang SC, Chang CH*. PLoS One. 2015 Apr 30;10(4):e0125518. § co-first author

36. Caffeic Acid Phenethyl Ester Induced Cell Cycle Arrest and Growth Inhibition in Androgen-Independent Prostate Cancer Cells via Regulation of Skp2, p53, p21^Cip1, and p27^Kip1. Lin HP^§, Lin CP^§, Hou C^§, Hsiao PH^§, Su LC, Jiang SS, Chan TM, Chang CH, Chen LT, Kung HJ, Wang HD, Chuu CP*. Oncotarget. 2015 Mar 30;6(9):6684-707.  *corresponding author

37. Applicability of Adipose-Derived Stem Cells in Type 1 Diabetes Mellitus. Lin HP, Chan TM, Fu RH, Chuu CP, Chiu SC, Tseng YH, Liu SP, Lai KC, Shih MC, Lin ZS, Chen HS, Yeh DC, Lin SZ*. Cell Transplant. 2015 ;24(3):521-32.

38. Reduced 5-methylcytosine level as a potential progression predictor in patients with t1 or non-invasive urothelial carcinoma. Chung CJ, Chang CH, Chuu CP, Yang CR, Chang YH, Huang CP, Chen WC, Chung MC, Chang H*. Int J Mol Sci. 2014 Dec 30;16(1):677-90.

39. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. Kokontis JM^§, Lin HP^§, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP*. PLoS One. 2014 Oct 1;9(10):e109170. *corresponding author

40. The use of ADSCs as a treatment for chronic stroke. Chan TM, Harn HJ, Lin HP, Chiu SC, Lin PC, Wang HI, Ho LI, Chuu CP, Chiou TW, Hsieh AC, Chen YW, Ho WY, Lin SZ*. Cell Transplant. 2014;23(4-5):541-7.

41. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer. Chuang CH, Wang WJ, Li CF, Ko CY, Chou YH, Chuu CP, Cheng TL, Wang JM*. Cell Death Dis. 2014 May 8;5:e1220.

42. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Leung KK, Hause RJ Jr, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB*. Mol Cell Proteomics. 2014 Jul;13(7):1705-23.

43. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. Fang WT, Fan CC, Li SM, Jang TH, Lin HP, Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, Liu YL, Tsai FY, Huang CT, Yang SJ, Yen LJ, Chuu CP, Chen CY, Hsiung CA, Chang JY, Wang LH, Chang IS, Jiang SS*. Int J Cancer. 2014 Aug 15;135(4):809-19.

44. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells. Lin HP, Lin CY, Hsiao PH, Wang HD, Sheng Jiang S, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP*. PLoS One. 2013 Dec 5;8(12):e82625. *corresponding author

45. Androgen receptor-mediated apoptosis in bovine testicular induced pluripotent stem cells in response to phthalate esters. Wang SW, Wang SS, Wu DC, Lin YC, Ku CC, Wu CC, Chai CY, Lee JN, Tsai EM, Lin CL, Yang RC, Ko YC, Yu HS, Huo C, Chuu CP, Murayama Y, Nakamura Y, Hashimoto S, Matsushima K, Jin C, Eckner R, Lin CS, Saito S, Yokoyama KK*. Cell Death Dis. 2013 Nov 7;4:e907.

46. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. Lin CY^§, Huo C^§, Kuo LK^§, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, Chen L, Yang SD, Fu HH, Chen YW, Tsai KK, Chang JY, Chuu CP*. PLoS One. 2013 Jun 13;8(6):e65734. *corresponding author

47. Caffeic Acid Phenethyl Ester Suppresses Proliferation and Survival of TW2.6 Human Oral Cancer Cells via Inhibition of Akt Signaling. Kuo YY, Lin HP, Huo C, Su LC, Yang J, Hsiao PH, Chiang HC, Chung CJ, Wang HD, Chang JY, Chen YW, Chuu CP*. International Journal of Molecular Sciences. 2013 Apr 24;14(5):8801-17. *corresponding author

48. SWAP-70: a new type of oncogene. Shu CL, Jing-Yang-Lai, Su LC, Chuu CP, Fukui Y*. PLoS One. 2013;8(3):e59245.

49. Synchronous triple carcinoma of the colon and rectum. Chien-Chih Yeh, Sheng-Chuan Hsi, Chih-Pin Chuu, Yung-Hsi Kao*. World J Surg Oncol. 2013 Mar 13;11:66.

50. Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. Lin HP^§, Lin CY^§, Liu CC^§, Su LC, Huo C, Kuo YY, Tseng JC, Hsu JM, Chen CK, Chuu CP*. International Journal of Molecular Sciences 2013 Mar 6;14(3):5264-83. *corresponding author

51. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Chun-Chieh Liu, Jong-Ming Hsu, Li-Kuo Kuo, Chih-Pin Chuu*. Med Hypotheses. 2013 May; 80(5):617-619. *corresponding author

52. Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. Hause RJ Jr, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB*. PLoS One. 2012;7(9):e44471.

53. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ Jr, Hiipakka RA, Liao S, Jones RB*. Cancer Prevention Research (Phila). 2012 May;5(5):788-97.

54. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. Lin HP, Jiang SS, Chuu CP*. PLoS One. 2012;7(2):e31286. *corresponding author

55. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. Chuu CP*, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Su LC. Journal of Biomedical Science. 2011 Aug 23;18:63. *corresponding author

56. Androgen Suppresses Proliferation of Castration-Resistant LNCaP 104-R2 Prostate Cancer Cells via Androgen Receptor, Skp2, and c-Myc. Chuu CP*, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Su LC, Liao S. Cancer Science. 2011 Nov;102(11):2022-8. *corresponding author

57. Combined Treatment of Curcumin and Small Molecule Inhibitors Suppresses Proliferation of A549 and H1299 Human Non-Small-Cell Lung Cancer Cells. Hui-Ping Lin§, Li-Kuo Kuo§, Chih-Pin Chuu*. Phytother Res. Phytother Res. 2012 Jan;26(1):122-6. *corresponding author

58. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Chih-Pin Chuu*. Med Hypotheses. 2011 May;76(5):697-9. *corresponding author *corresponding author

59. Antiproliferative effect of LXR agonists T0901317 and 22(R)-Hydroxycholesterol on multiple human cancer cell lines. Chih-Pin Chuu* and Hui-Ping Lin. Anticancer Res. 2010 Sep; 30(9):3643-3648. *corresponding author

60. Systems Analysis of EGF Receptor Signaling Dynamics with Micro-Western Arrays. Ciaccio MP, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB*. Nat Methods. 2010 Feb;7(2):148-55.

61. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Chuu CP*, Chen RY, Kokontis JM, Hiipakka RA, Liao S*. Cancer Lett. 2009 Mar 8;275(1):86-92. *co-corresponding author

62. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB*. Mol Cancer Res. 2008 Jun;6(6):885-91.

63. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Chuu CP, Chen RY, Hiipakka RA, Kokontis JM, Warner KV, Xiang J, Liao S*. Biochem Biophys Res Commun. 2007 Jun 1;357(2):341-6.

64. Modulation of liver X receptor signaling as novel therapy for prostate cancer. Chuu CP, Kokontis JM, Hiipakka RA, Liao S*. J Biomed Sci. 2007 Sep;14(5):543-53.

65. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S*. Cancer Res. 2006 Jul 1;66(13):6482-6.

66. Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Chuu CP, Hiipakka RA, Fukuchi J, Kokontis JM, Liao S*. Cancer Res. 2005 Mar 15;65(6):2082-4.

67. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S*. Prostate. 2005 Dec 1;65(4):287-98.

68. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S*. Cancer Res. 2004 Nov 1;64(21):7686-9.

1.     NHRI Young Investigator Award 2017.

2.     Academic Editor of PLOS One (2013-present)

3.     Selected for 2011-2012 Edition Marquis Who is Who in Medicine and Healthcare

4.     Selected for 2011 Edition Marquis Who's Who